Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

NeoPharm files IND for antibody-targeted toxin

May 3, 2000

Patent licensed to GenStar covers gene therapy for sensitizing tumors to radiation

May 3, 2000

Coulter and SB modify Bexxar collaboration; phase II combination trial commences

May 3, 2000

Paxene receives marketing approval in Canada for Kaposi's sarcoma

May 2, 2000

ImClone Systems receives notice of allowability for cancer immunotherapy

May 2, 2000

Aphton begins trial of anti-G17 immunogen in metastatic gastric cancer

May 2, 2000

Novel platinum antitumor agent compares favorably with cisplatin in preclinical studies

May 2, 2000

Selectin inhibitors under study by Otsuka

May 2, 2000

Treatment and diagnosis of tumors using urokinase inhibitors

May 2, 2000

Swainsonine analogues in development at GlycoDesign as therapeutic agents

May 2, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 27, 2026.
Brain-penetrant NLRP3 inhibitor shows promise in Parkinson’s
BioWorld Science
Researchers from Changchun Genescience Pharmaceuticals Co. Ltd. described the discovery and preclinical profile of an NLRP3 inhibitor with favorable brain...
4D Nucleome opens new wave of gene regulation research, discovery
BioWorld
After a decade of research, the NIH 4D Nucleome program on July 23 delivered a wealth of new insights into how spatial changes in chromatin structure and DNA...
Daybu readthrough in EU? Zevra’s NPC bid flounders
BioWorld
Zevra Therapeutics Inc. will try to follow in the footsteps of Acadia Pharmaceuticals Inc. with Rett syndrome drug Daybu (trofinetide) by asking the EMA’s...
Transcripta Bio raises funding to advance neuro pipeline
BioWorld Science
Transcripta Bio Inc. has raised $24 million since its series A to fund IND-enabling studies across its portfolio and support clinical preparation in its autism...